Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Insulin resistance and cigarette smoking.

Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM.

Lancet. 1992 May 9;339(8802):1128-30. Erratum in: Lancet 1992 Jun 13;339(8807):1492.

PMID:
1349365
2.

Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.

Rubies-Prat J, Ordóñez-Llanos J, Martin S, Blanco-Vaca F, Molina L, Goday A, Pedro-Botet J.

Clin Exp Hypertens. 2001 Aug;23(6):489-500. Erratum in: Clin Exp Hypertens 2001 Nov;23(8):667.

PMID:
11478431
3.

The relationship between insulin resistance and dyslipidaemia in cigarette smokers.

Farin HM, Abbasi F, Kim SH, Lamendola C, McLaughlin T, Reaven GM.

Diabetes Obes Metab. 2007 Jan;9(1):65-9.

PMID:
17199720
4.

Prospective evaluation of insulin resistance and lipid metabolism in women receiving oral contraceptives.

Sheu WH, Hsu CH, Chen YS, Jeng CY, Fuh MM.

Clin Endocrinol (Oxf). 1994 Feb;40(2):249-55.

PMID:
8137525
5.

Hyperinsulinaemia, obesity, and syndrome X.

Zavaroni I, Bonini L, Fantuzzi M, Dall'Aglio E, Passeri M, Reaven GM.

J Intern Med. 1994 Jan;235(1):51-6.

PMID:
8283160
6.

Dyslipoproteinemic changes in borderline hypertension.

Lemne C, Hamsten A, Karpe F, Nilsson-Ehle P, de Faire U.

Hypertension. 1994 Nov;24(5):605-10.

7.

Resistance to insulin-stimulated glucose uptake and dyslipidemia in Asian Indians.

Laws A, Jeppesen JL, Maheux PC, Schaaf P, Chen YD, Reaven GM.

Arterioscler Thromb. 1994 Jun;14(6):917-22.

8.
9.

Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.

Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, Pugh K, Jenkins AJ, Klein RL, Liao Y.

Diabetes. 2003 Feb;52(2):453-62.

10.

Impact of chronic cigarette smoking on body composition and fuel metabolism.

Jensen EX, Fusch C, Jaeger P, Peheim E, Horber FF.

J Clin Endocrinol Metab. 1995 Jul;80(7):2181-5.

PMID:
7608276
11.

Coronary artery disease risk predicted by insulin resistance, plasma lipids, and hypertension in people without diabetes.

Sheu WH, Jeng CY, Young MS, Le WJ, Chen YT.

Am J Med Sci. 2000 Feb;319(2):84-8.

PMID:
10698091
12.

Fasting remnant lipoprotein cholesterol and triglyceride concentrations are elevated in nondiabetic, insulin-resistant, female volunteers.

Abbasi F, McLaughlin T, Lamendola C, Yeni-Komshian H, Tanaka A, Wang T, Nakajima K, Reaven GM.

J Clin Endocrinol Metab. 1999 Nov;84(11):3903-6.

PMID:
10566626
13.

Hyperinsulinemia is characterized by jointly disturbed plasma VLDL, LDL, and HDL levels. A population-based study.

Modan M, Halkin H, Lusky A, Segal P, Fuchs Z, Chetrit A.

Arteriosclerosis. 1988 May-Jun;8(3):227-36.

14.

Cigarette smoking, adiposity, non-insulin-dependent diabetes, and coronary heart disease in Japanese-American men.

Fujimoto WY, Leonetti DL, Bergstrom RW, Shuman WP, Wahl PW.

Am J Med. 1990 Dec;89(6):761-71.

PMID:
1979206
15.

Plasma lipoproteins and incidence of non-insulin-dependent diabetes mellitus in Pima Indians: protective effect of HDL cholesterol in women.

Fagot-Campagna A, Narayan KM, Hanson RL, Imperatore G, Howard BV, Nelson RG, Pettitt DJ, Knowler WC.

Atherosclerosis. 1997 Jan 3;128(1):113-9.

PMID:
9051204
17.

Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia.

Zavaroni I, Mazza S, Fantuzzi M, Dall'Aglio E, Bonora E, Delsignore R, Passeri M, Reaven GM.

J Intern Med. 1993 Jul;234(1):25-30.

PMID:
8326285
18.

Lipoproteins abnormalities in obese insulin-resistant dogs.

Bailhache E, Nguyen P, Krempf M, Siliart B, Magot T, Ouguerram K.

Metabolism. 2003 May;52(5):559-64.

PMID:
12759884
20.

Effect of gemfibrozil treatment in sulfonylurea-treated patients with noninsulin-dependent diabetes mellitus.

Shen DC, Fuh MM, Shieh SM, Chen YD, Reaven GM.

J Clin Endocrinol Metab. 1991 Sep;73(3):503-10.

PMID:
1874929

Supplemental Content

Support Center